NextPlat Corp. (NASDAQ:NXPL) Sees Significant Decrease in Short Interest

NextPlat Corp. (NASDAQ:NXPL) was the target of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 332,400 shares, a decrease of 26.1% from the May 15th total of 449,800 shares. Currently, 2.4% of the shares of the company are short sold. Based on an average daily trading volume, of 210,300 shares, the short-interest ratio is currently 1.6 days.

Hedge Funds Weigh In On NextPlat

A hedge fund recently raised its stake in NextPlat stock. Geode Capital Management LLC grew its stake in NextPlat Corp. (NASDAQ:NXPL) by 54.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 165,459 shares of the company’s stock after acquiring an additional 58,402 shares during the period. Geode Capital Management LLC owned 0.64% of NextPlat worth $179,000 as of its most recent filing with the Securities and Exchange Commission. 1.30% of the stock is currently owned by institutional investors and hedge funds.

NextPlat Stock Performance

Shares of NASDAQ NXPL opened at $0.68 on Wednesday. The business has a fifty day simple moving average of $0.60 and a 200 day simple moving average of $0.87. The firm has a market capitalization of $17.73 million, a price-to-earnings ratio of -1.05 and a beta of 0.89. NextPlat has a one year low of $0.43 and a one year high of $2.30. The company has a current ratio of 3.62, a quick ratio of 3.08 and a debt-to-equity ratio of 0.04.

NextPlat (NASDAQ:NXPL) last released its quarterly earnings data on Thursday, May 15th. The company reported ($0.05) EPS for the quarter. The business had revenue of $14.53 million for the quarter. NextPlat had a negative return on equity of 13.76% and a negative net margin of 22.21%.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.